HBW 023 (recombinant hirudin) for the acceleration of thrombolysis and prevention of coronary reocclusion in acute myocardial infarction: results of a dose‐finding study (HIT‐II) by the Arbeitsgemeinschaft Leitender Kardiologischer Krankenhausärzte